Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate
BCA-81472709
Phase 1 small_molecule active
Quick answer
Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate for Breast Cancer is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active